Status:
COMPLETED
Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19
Lead Sponsor:
Centre Hospitalier Universitaire Saint Pierre
Conditions:
Anosmia
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Olfactory dysfunction (OD) is a well know symptom of coronavirus disease 2019 (COVID-19), accounting for 48 to 85% of patients. In 1 to 10% of cases, patients develop a chronic olfactory dysfunction (...
Eligibility Criteria
Inclusion
- Patient chronic olfactory dysfunction lasting more than 6 months after an infection of COVID-19
Exclusion
- Patient under 18 years old
- Patient with blood disorder
- Blood thinner user
- Patient with abnormal findings on nasal endoscopy (e.g., polyposis, rhinosinusitis)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05226546
Start Date
February 1 2021
End Date
August 1 2021
Last Update
February 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU saint pierre
Brussels, Belgium, 1000